Brain Scientific announced that Brainbox fully tested Brain Scientific's NeuroCap and will integrate them into their client solutions. Brainbox brings together decades of technical and academic expertise to provide a wide range of customizable solutions, together with expert hands-on training to satisfy even the most demanding of non-invasive brain stimulation research studies. Brainbox enables the very best neuroscience research with tailored and integrated non-invasive brain stimulation and brain imaging solutions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -31.82% | -.--% | -.--% |
2023 | Brain Scientific Inc. cancelled the acquisition of IMAC Holdings, Inc.. | CI |
2023 | Brain Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 932K | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- BRSF Stock
- News Brain Scientific Inc.
- Brainbox Validates NeuroCap(Tm) in Testing Regimen; Adds Them to Its Sports Medicine and Pharma Solutions